Douglas Skarada, MD
Otolaryngology · Salem, ORNPI 1770588949
Payments from drug & device makers
What this record shows
Medtronic accounts for 68.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $3,414 and has fallen 97.2% since, to $95 in 2025. Among otolaryngology clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $84.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Stryker$2K
- Somnomed Inc.$302
- Aerin Medical Inc.$90
- Kaleo, Inc.$58
- Regeneron Healthcare Solutions, Inc.$37
- plus $58 from 4 others
What the payments were for
- Travel & lodging$3,42852%
- Food & beverage$3,18948%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 47 | $4,516 |
| Stryker | 20 | $1,554 |
| Somnomed Inc. | 1 | $302 |
| Aerin Medical Inc. | 2 | $90 |
| Kaleo, Inc. | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Intersect ENT, Inc. | 1 | $27 |
| Acclarent, Inc | 1 | $14 |
| Optinose US, Inc. | 1 | $12 |
| Xoran Technologies LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SINUVA$1,647
- NUVENT$1,528
- SCOPIS ENT$932
- PROPEL$467
How this compares
$6,617 in reported general payments places this provider in the 90th percentile of 128 otolaryngology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 55 | $751 |
| Ipratropium Bromide | 25 | $565 |
| Azelastine Hcl | 15 | $300 |
| Azithromycin | 12 | $99 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Salem
- Christopher PrzeSalem$5K
- Suzanne StrandSalem$3K
- John DonovanSalem$666
- Mathew GeltzeilerPortland$221K
- Ryan LiPortland$160K
- Jeremiah AltPortland$89K
- Mark WaxPortland$20K
- Marcus MonroePortland$16K
- Joshua SchindlerPortland$8K
- Andrew BakerMilwaukie$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.